Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Elevance Health (ELV)

Tipranks - Tipranks - Mon Feb 2, 9:52PM CST

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX – Research Report) and Elevance Health (ELV – Research Report) with bullish sentiments.

Claim 50% Off TipRanks Premium

Elevance Health (ELV)

In a report released yesterday, Ryan Langston from TD Cowen maintained a Buy rating on Elevance Health, with a price target of $400.00. The company’s shares closed last Friday at $345.74.

According to TipRanks.com, Langston is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -7.3% and a 41.1% success rate. Langston covers the Healthcare sector, focusing on stocks such as Alignment Healthcare, Privia Health Group, and P3 Health Partners. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Elevance Health with a $391.00 average price target, implying a 12.4% upside from current levels. In a report issued on January 30, TipRanks – PerPlexity also upgraded the stock to Buy with a $382.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).